Mr. Chris Wagner reports

EMERALD HEALTH THERAPEUTICS NAMED AS CANNABIS SUPPLIER BY NEWFOUNDLAND LABRADOR LIQUOR CORPORATION TO PROVIDE ADULT-USE CANNABIS PRODUCTS

Emerald Health Therapeutics Inc. has been selected as an authorized cannabis supplier by the Newfoundland Labrador Liquor Corp. (NLC) to supply cannabis products to the NLC and serve the adult-use market throughout the province of Newfoundland and Labrador starting Oct. 17.

"We're proud to work with the NLC as a preferred licensed producer to serve Newfoundland and Labrador in the upcoming legal cannabis market," said Chris Wagner, chief executive officer at Emerald. "This represents the third provincial agreement for our team and we expect to share additional supply updates in the future."

With its previously announced supply agreements with the provinces of British Columbia and Ontario, as well as its commercial production facilities quickly ramping up in British Columbia and Quebec, Emerald is prepared for the adult-use market. The company is focused on product innovation that will command high profit margins; differentiating its marketing strategy; and securing significant supplies of safe, quality, low-cost cannabis.

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics is a licensed producer under Canada's Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. Emerald owns 50 per cent of Pure Sunfarms, which is converting a licensed existing 1.1-million-square-foot greenhouse in Delta, B.C., and is in commercial production. It owns Agro-Biotech, a Quebec-based licensed cannabis grower with a 75,000-square-foot indoor facility and is planning to add a 500,000-square-foot greenhouse in Metro Vancouver. Emerald's team is highly experienced in life sciences, product development, large-scale agri-business and marketing, and is focused on developing value-added cannabis-based products with potential wellness and medical benefits.

We seek Safe Harbor.